Ologen (OculusGen)-Glaucoma Case Control Trial in India

NCT00448929 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pro Top & Mediking Company Limited